Molecule.one grows its drug synthesis AI platform with a $4.6M seed round

by Dr. Marcus Erken

Announcing our investment in RANDAEMON, which is building true random number generators to enable more secure…

by Dr. Marcus Erken

Our interview for the new Polish VC report

by Dr. Marcus Erken

Our mission has been clear from the beginning: we want to teach computers organic chemistry and use our…

by Dr. Marcus Erken

Announcing our investment in Solvemed Group, which aims to revolutionize Parkinson’s disease care

by Dr. Marcus Erken

[New Video] How the Venture Capital Industry is Changing

by Dr. Marcus Erken

We could not be more excited to announce that Paweł Lipkowski has joined us as Head of Finance & Operations

Today marks a special day for us. For the first time, we have added a member to…

by Dr. Marcus Erken